Literature DB >> 8490473

Antibody persistence after accelerated immunisation against Haemophilus influenzae type b.

R Booy1, S Hodgson, H Griffiths, H M Chapel, E R Moxon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8490473      PMCID: PMC1677465          DOI: 10.1136/bmj.306.6883.971

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Efficacy of Haemophilus influenzae type B conjugate vaccine in Oxford region.

Authors:  R Booy; E R Moxon; J A MacFarlane; R T Mayon-White; M P Slack
Journal:  Lancet       Date:  1992-10-03       Impact factor: 79.321

2.  Haemophilus influenzae type b conjugate vaccine trial in Oxford: implications for the United Kingdom.

Authors:  G Tudor-Williams; J Frankland; D Isaacs; R T Mayon-White; J A MacFarlane; D G Rees; E R Moxon
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

3.  Safety and immunologic response to Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in 1- to 6-month-old infants.

Authors:  D V Madore; C L Johnson; D C Phipps; L A Popejoy; R Eby; D H Smith
Journal:  Pediatrics       Date:  1990-03       Impact factor: 7.124

4.  Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule.

Authors:  R Booy; S A Taylor; S R Dobson; D Isaacs; G Sleight; S Aitken; H Griffiths; H Chapel; R T Mayon-White; J A Macfarlane
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

5.  Epidemiology of Haemophilus influenzae type b invasive disease in Wales.

Authors:  A J Howard; K T Dunkin; J M Musser; S R Palmer
Journal:  BMJ       Date:  1991-08-24
  5 in total
  3 in total

1.  Antibody persistence and Haemophilus influenzae type b carriage after infant immunisation with PRP-T.

Authors:  P T Heath; J Bowen-Morris; D Griffiths; H Griffiths; D W Crook; E R Moxon
Journal:  Arch Dis Child       Date:  1997-12       Impact factor: 3.791

Review 2.  Conjugate vaccines and the carriage of Haemophilus influenzae type b.

Authors:  M L Barbour
Journal:  Emerg Infect Dis       Date:  1996 Jul-Sep       Impact factor: 6.883

Review 3.  Rational use of Haemophilus influenzae type b vaccine.

Authors:  Harry Campbell; Harden Carter
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.